PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion

NCT05343715 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Fabry Disease

Interventions

BIOLOGICAL: Agalsidase beta from Biosidus 1 mg/kg
BIOLOGICAL: Fabrazyme (agalsidase beta) 1 mg/kg

Sponsor

Bio Sidus SA